Pfizer weighs $15 billion sale of consumer healthcare business

Pfizer weighs $15 billion sale of consumer healthcare business Pfizer said on Tuesday it was considering the sale or spin-off of its consumer healthcare business, shaking up the industry and potentially putting a headache pill to lip balm operation worth some $15 billion up for grabs. The move comes as […]